| 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study MC van Maaren, L de Munck, GH de Bock, JJ Jobsen, T van Dalen, ... The Lancet Oncology 17 (8), 1158-1170, 2016 | 431 | 2016 |
| 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study MC van Maaren, L de Munck, GH de Bock, JJ Jobsen, T van Dalen, ... The Lancet Oncology 17 (8), 1158-1170, 2016 | 430 | 2016 |
| Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survival A Moncada-Torres, MC van Maaren, MP Hendriks, S Siesling, ... Scientific reports 11 (1), 6968, 2021 | 182 | 2021 |
| Breast conserving therapy and mastectomy revisited: Breast cancer‐specific survival and the influence of prognostic factors in 129,692 patients M Lagendijk, MC van Maaren, S Saadatmand, LJA Strobbe, ... International journal of cancer 142 (1), 165-175, 2018 | 164 | 2018 |
| Ten‐year recurrence rates for breast cancer subtypes in The Netherlands: a large population‐based study MC van Maaren, L de Munck, LJA Strobbe, GS Sonke, PJ Westenend, ... International journal of cancer 144 (2), 263-272, 2019 | 139 | 2019 |
| Validation of the online prediction tool PREDICT v. 2.0 in the Dutch breast cancer population MC van Maaren, CD van Steenbeek, PDP Pharoah, A Witteveen, ... European journal of cancer 86, 364-372, 2017 | 54 | 2017 |
| Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 … MC van Maaren, L de Munck, JJ Jobsen, P Poortmans, GH de Bock, ... Breast cancer research and treatment 160, 511-521, 2016 | 48 | 2016 |
| Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands … DJ van Der Meer, I Kramer, MC van Maaren, PJ van Diest, S C Linn, ... International journal of cancer 148 (9), 2289-2303, 2021 | 45 | 2021 |
| Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer DJP Van Uden, MC Van Maaren, LJA Strobbe, P Bult, JJ Van Der Hoeven, ... Breast cancer research 21, 1-9, 2019 | 45 | 2019 |
| Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer DJP Van Uden, MC van Maaren, P Bult, LJA Strobbe, ... Breast cancer research and treatment 176, 217-226, 2019 | 43 | 2019 |
| The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival MC Van Maaren, RW Bretveld, JJ Jobsen, RK Veenstra, ... British journal of cancer 117 (2), 179-188, 2017 | 41 | 2017 |
| Machine learning explainability in breast cancer survival T Jansen, G Geleijnse, M Van Maaren, MP Hendriks, A Ten Teije, ... 30th Medical Informatics Europe Conference, MIE 2020, 307-311, 2020 | 33 | 2020 |
| Nationwide population-based study of trends and regional variation in breast-conserving treatment for breast cancer MC van Maaren, LJA Strobbe, LB Koppert, PMP Poortmans, S Siesling Journal of British Surgery 105 (13), 1768-1777, 2018 | 22 | 2018 |
| Anticyclic citrullinated peptide antibodies and rheumatoid factor as risk factors for 10-year cardiovascular morbidity in patients with rheumatoid arthritis: a large inception … MLT Berendsen, MC van Maaren, EEA Arts, AA den Broeder, CD Popa, ... The Journal of Rheumatology 44 (9), 1325-1330, 2017 | 22 | 2017 |
| Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model V Völkel, TA Hueting, T Draeger, MC van Maaren, L de Munck, ... Breast cancer research and treatment 189, 817-826, 2021 | 19 | 2021 |
| Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: taking account of event-free years MC van Maaren, LJA Strobbe, ML Smidt, M Moossdorff, PMP Poortmans, ... European Journal of Cancer 102, 82-94, 2018 | 19 | 2018 |
| Breast cancer–related deaths according to grade in ductal carcinoma in situ: A Dutch population–based study on patients diagnosed between 1999 and 2012 MC Van Maaren, M Lagendijk, MMA Tilanus-Linthorst, L de Munck, ... European Journal of Cancer 101, 134-142, 2018 | 19 | 2018 |
| Validation and update of a lymph node metastasis prediction model for breast cancer SQ Qiu, M Aarnink, MC van Maaren, MD Dorrius, A Bhattacharya, ... European Journal of Surgical Oncology 44 (5), 700-707, 2018 | 16 | 2018 |
| Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands CD van Steenbeek, MC van Maaren, S Siesling, A Witteveen, ... BMC medical research methodology 19, 1-8, 2019 | 15 | 2019 |
| Better survival after surgery of the primary tumor in stage IV inflammatory breast cancer DJP van Uden, MC van Maaren, LJA Strobbe, P Bult, MR Stam, ... Surgical Oncology 33, 43-50, 2020 | 14 | 2020 |
